The Dairy Alternatives Market to hit $37.5 billion by 2025: Global Market Insights, Inc.
March 11, 2019 07:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, March 11, 2019 (GLOBE NEWSWIRE) -- The unsweetened segment constitutes a major share in the dairy alternatives market. The segment does not contain added sugar or...
Athenex, Inc. Announces Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update
March 11, 2019 07:00 ET
|
Athenex, Inc.
Oraxol Phase III clinical trial in metastatic breast cancer fully enrolled Positive Phase III topline results of KX2-391 in actinic keratosis featured in late breaker session at recent 2019 AAD...
Orchard Therapeutics Announces Acceptance of OTL-200 Abstract for MLD at the 45th Annual Meeting of the European Society for Blood and Bone Marrow Transplantation (EBMT)
March 11, 2019 07:00 ET
|
Orchard Therapeutics Limited
BOSTON and LONDON, March 11, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with...
RedHill Biopharma to Present at the 31st Annual ROTH Conference
March 11, 2019 07:00 ET
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel and RALEIGH, N.C., March 11, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty...
NVIDIA to Acquire Mellanox for $6.9 Billion
March 11, 2019 07:00 ET
|
NVIDIA
Unites leaders in processing and interconnect for the high performance computing marketBuilds on the companies’ long history of collaboration and joint innovationExpected to be accretive to NVIDIA’s...
Emerald Health Therapeutics Sees Pure Sunfarms Licensed for 1.03 Million Square Feet of Cannabis Cultivation; Full Planting Targeted for End of April
March 11, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale,...
Eurocontrol Announces Special Meeting Date
March 11, 2019 07:00 ET
|
Eurocontrol Technics Group Inc.
TORONTO, March 11, 2019 (GLOBE NEWSWIRE) -- Eurocontrol Technics Group Inc. (TSX Venture: EUO; OTCQB: EUCTF) (“Eurocontrol” or the “Company”) announces that a special meeting of holders of common...
Shareholders’ Gold Council Condemns Goldcorp’s Board of Directors
March 11, 2019 07:00 ET
|
Shareholders' Gold Council
TORONTO, March 11, 2019 (GLOBE NEWSWIRE) -- On March 7, Goldcorp filed its proxy circular in connection with its proposed acquisition by Newmont, where it was disclosed that: “In contemplation of...
NeuBase Therapeutics Announces Agreements for $9 Million Financing
March 11, 2019 07:00 ET
|
NeuBase Therapeutics, Inc.
PITTBURGH, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (“NeuBase”), a biotechnology company developing next generation antisense therapies to address rare genetic diseases,...
Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline
March 11, 2019 07:00 ET
|
Stemline Therapeutics, Inc.
NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel...
- May 07, 2024 15:30 ET Doximity, Inc. Stockholders Should Contact Robbins LLP Regarding Impeding Lead Plaintiff Deadline in DOCS Securities Class Action
- May 07, 2024 15:28 ET Sharecare, Inc. Stockholders Should Contact Robbins LLP Regarding the Pending Lead Plaintiff Deadline in the SHCR Securities Class Action